Study: Mammography market revitalized by new technologies
The North American x-ray mammography markets are receiving renewed impetus from the launch of several new digital mammography technologies, according to San Jose, Calif.-based market research firm Frost & Sullivan. These include both computed radiography and flat-panel direct radiography technology, which are considered to be full-field digital mammography (FFDM) techniques, the company said.
Frost & Sullivan said that revenues from this market segment reached $380.9 million USD last year and are likely to reach $563.5 million by 2013.
FFDM technologies are driving the strong growth of the North American X-ray mammography markets, with their United States installed base increasing from 3.3 percent in November 2003 to 13.8 percent in October 2006, according to the research group.
The number of newly installed FFDM units every month increased steadily by 333 percent from December 2003 to February 2006 and in the eight-month period from February 2006 to October 206, monthly installed units increased by 368 percent, the firm added.
Frost & Sullivan noted that digital breast tomosynthesis, or 3D mammography, is an emerging technology that could potentially increase the revenues of the X-ray mammography markets. Industry participants speculate that the DBT technology may receive U.S. Food and Drug Administration approval by 2008.
Frost & Sullivan said that revenues from this market segment reached $380.9 million USD last year and are likely to reach $563.5 million by 2013.
FFDM technologies are driving the strong growth of the North American X-ray mammography markets, with their United States installed base increasing from 3.3 percent in November 2003 to 13.8 percent in October 2006, according to the research group.
The number of newly installed FFDM units every month increased steadily by 333 percent from December 2003 to February 2006 and in the eight-month period from February 2006 to October 206, monthly installed units increased by 368 percent, the firm added.
Frost & Sullivan noted that digital breast tomosynthesis, or 3D mammography, is an emerging technology that could potentially increase the revenues of the X-ray mammography markets. Industry participants speculate that the DBT technology may receive U.S. Food and Drug Administration approval by 2008.